Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison

BACKGROUND: Recent meta-analyses have found a survival advantage with gemcitabine based combinations over single agent gemcitabine in patients with advanced pancreatic cancer. There is paucity of evidence in the form of direct head-to-head randomised controlled trials to determine which combinations...

Full description

Saved in:
Bibliographic Details
Main Authors: Sultana, Asma, Ghaneh, Paula, Cunningham, David, Starling, Naureen, Neoptolemos, John P, Smith, Catrin Tudur
Format: Artigo
Language:Inglês
Published: BioMed Central 2008
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2474853/
https://ncbi.nlm.nih.gov/pubmed/18611273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-192
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items